Preeclampsia. Gestational [pregnancy-induced] hypertension with significant proteinuria
Conditions
Interventions
Intervention 1: Omega-3, 1gram for 24 weeks. Intervention 2: Placebo for 24 weeks.
Treatment - Drugs
Placebo
Omega-3, 1gram for 24 weeks
Placebo for 24 weeks
Sponsors
Qazvin University of Medical Sciences, Zahravi drug company
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: pregnant women whose gestational age is between 14 to 18 weeks and are ready to cooperate, being high risk for preeclampsia (first gravidy, under the age of 20 and over 40, a history of preeclampsia during the previous gravidy or immediate member of family, BMI more than 29, history of twin fetuses); Inclusion criteria: consumption of Aspirin, Calcium, anticoagulants, allergy to omega3 or fish, presence digestive diseases which need to treatment,
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypertention. Timepoint: Every 4 hours. Method of measurement: determination of BP by the auscullatory method.;Proteinuria. Timepoint: daily. Method of measurement: Urine Protein. | — |
Secondary
| Measure | Time frame |
|---|---|
| Level of liver enzymes. Timepoint: daily. Method of measurement: laboratory.;Headache. Timepoint: Every 4 hours. Method of measurement: Asking from patients.;Thrombocytopenia. Timepoint: daily. Method of measurement: laboratory.;Abdominal pain. Timepoint: Every 4 hours. Method of measurement: Asking from pateints.;Vision problems. Timepoint: Every 4 hours. Method of measurement: Asking from patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Ranjkesh
nursing and midwifery school
Outcome results
None listed